
July 30, 2024
Avenira Limited (ASX: AEV) (“Avenira” or “the Company”)”) has secured a Strategic Investment from its largest shareholder, Sichuan Hebang Biotechnology Corporation Limited (SHSE: 603077) (“Hebang”).
HIGHLIGHTS:
- Avenira Limited (ASX: AEV) (“Avenira” or “the Company”) has secured a Strategic Investment from its largest shareholder, Sichuan Hebang Biotechnology Corporation Limited (SHSE: 603077) (“Hebang”).
- The Strategic Investment comprises:
- A$4.5 million 2-tranche Placement at an issue price of A$0.006 per new share, with Tranche 2 subject to shareholder approval and any other required regulatory approvals.
- Pending shareholder approval for Tranche 2 Hebang will provide an unsecured loan of the Tranche 2 proceeds.
- Funds from the Placement will be used for progressing the Yellow Phosphate study work, Lithium Ferro Phosphate study work and for general working capital.
- As part of the investment, Hebang has the right to appoint an Executive Chairman and two directors to the Board, as well as a Chief Executive Officer and Chief Financial Officer to the management team.
Strategic Investment
- Tranche 1 Placement: Tranche 1 will raise A$1.7 million through the issue of 285,000,000 shares, at an issue price of A$0.006 per new share. These shares will be issued on or around 2 August under the Company’s existing Listing Rule 7.1 (223 million shares) and 7.1A (62 million shares) placement capacity (“Tranche 1”).
- Tranche 2 Placement: Tranche 2 will raise A$2.79 million through the issue of 465,000,000 shares at the same price as Tranche 1 (“Tranche 2”). As the issue of the Tranche 2 shares will mean Hebang has an interest in the issued capital of the Company of greater than 20%, shareholder approval pursuant to Item 7 of Section 611 of the Corporations Act (Cth) 2001 will be required for the issue of shares under Tranche 2. Tranche 2 is also subject to any other required regulatory approvals
- Unsecured loan: Hebang will also provide an unsecured loan of the Tranche 2 placement proceeds pending shareholder approval and any other required regulatory approvals for the Tranche 2 placement. The terms of the loan are:
- Principal - $2.79 million;
- Repayment – Repayment of principal and interest upon the earlier of either the completion of Tranche 2 placement or 12 months
- Interest – 12% pa capitalised and payable on repayment of principal
The unsecured loan will be repaid from funds received from the Tranche 2 placement.
If the Shareholders Approval or any other regulatory approval required for Tranche 2 is not obtained by 31 October 2024, given the company’s history of raising capital to date, the directors are confident of the company’s ability to raise additional funds through a placement, rights issue, SPP, convertible note or other capital raising method previously utilized by the Company, when the unsecured loan is due for repayment, on or around September 2025.
Click here for the full ASX Release
This article includes content from Avenira Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.AEV:AU
The Conversation (0)
17 June
Wonarah Mine Management Plan Approved by the NT Government
Avenira Limited (AEV:AU) has announced Wonarah Mine Management Plan Approved by the NT GovernmentDownload the PDF here. Keep Reading...
30 April
Quarterly Activities/Appendix 5B Cash Flow Report
Avenira Limited (AEV:AU) has announced Quarterly Activities/Appendix 5B Cash Flow ReportDownload the PDF here. Keep Reading...
09 March
Investment from Sichuan Hebang Biotechnology
Avenira Limited (AEV:AU) has announced Investment from Sichuan Hebang BiotechnologyDownload the PDF here. Keep Reading...
11 February
Termination of Aleees License and Technology Agreement
Avenira Limited (AEV:AU) has announced Termination of Aleees License and Technology AgreementDownload the PDF here. Keep Reading...
15 October
7 Biggest Lithium-mining Companies in 2025
For a long time, most of the world's lithium was produced by an oligopoly of US-listed producers. However, the sector has transformed significantly in recent years.Interested investors should cast a wider net to look at global companies — in particular those listed in Australia and China, as... Keep Reading...
15 October
Livium Ltd (ASX: LIT) – Trading Halt
Trading in the securities of Livium Ltd (‘LIT’) will be halted at the request of LIT, pending the release of an announcement by LIT. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of: the commencement of normal trading on Friday, 17 October 2025; orthe... Keep Reading...
14 October
GM Takes US$1.6 Billion Hit on EV Realignment as US Policy Shift Clouds Market Outlook
General Motors (NYSE:GM) will take a US$1.6 billion charge tied to its electric vehicle (EV) production realignment as the federal government rolls back clean energy incentives and emissions standards.In a regulatory filing on Tuesday (October 14), GM said the charges include a US$1.2 billion... Keep Reading...
13 October
EUR Sells a Further 3.85 Million CRML Shares for US$50M (A$76M) to a US Institutional Investor
European Lithium Ltd (ASX: EUR, FRA:PF8, OTC: EULIF) (European Lithium or the Company) is pleased to announce that Critical Metals Corp. (Nasdaq: CRML) in an off-market transaction has sold a further 3.85 million CRML shares to a single US institutional investor at US$13 per share (a 12%... Keep Reading...
12 October
Successful A$4.5m Two Tranche Placement
Green Technology Metals (GT1:AU) has announced Successful A$4.5m Two Tranche PlacementDownload the PDF here. Keep Reading...
10 October
Chairman on India Trade Mission with PM
Robin Brundle joins Prime Minister on first major trade mission to IndiaMr Brundle joins 125-strong delegation of leading business representatives, academic and cultural leaders, and government ministers on UK's largest ever trade mission to IndiaTechnology Minerals Plc (LSE: TM1), the first UK... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00